Drugs / AGS-006
last change Oct 2011 re-read 3 minutes ago

AGS-006

Developed for
malignant pancreatic neoplasm
Investigated by
Argos Therapeutics

Trials 1

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT00664482 May 2007 → Oct 2011 malignant pancreatic neoplasm Argos Therapeutics Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as AGS-006 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00664482 ↗